Literature DB >> 15780101

Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program.

Tarek M El-Achkar1, Suzanne E Ohmit, Peter A McCullough, Errol D Crook, Wendy W Brown, Richard Grimm, George L Bakris, William F Keane, John M Flack.   

Abstract

BACKGROUND: The Kidney Early Evaluation Program (KEEP 2.0) cross-sectional, community-based study, targeted individuals at increased risk for kidney disease and measured blood glucose, creatinine, and hemoglobin.
METHODS: KEEP 2.0 screening data were used to determine the prevalence of anemia by level of kidney function and diabetes status. Estimated glomerular filtration rate (EGFR) was calculated using serum creatinine values, and categorized as > or =90, 60-89, 30-59 and <30 mL/min/1.73 m(2). Anemia was defined as hemoglobin <12 g/dL in men and in women aged >50 years, and <11 g/dL in women < or =50 years. Diabetes was defined as participant-reported diagnosis, fasting glucose >125 mg/dL, or nonfasting glucose >200 mg/dL.
RESULTS: Data were available on 5380 participants screened from August 2000 through December 2001. Diabetes was present in 26.9% of participants, and anemia in 7.7%; 15.9% of participants had at least moderately reduced kidney function (EGFR <60 mL/min/1.73 m(2)). In participants with diabetes, anemia prevalence at the 4 levels of descending EGFR were 8.7%, 7.5%, 22.2%, and 52.4%, compared with 6.9%, 5.0%, 7.9%, and 50.0% in persons without diabetes. In a multivariable model, participants of non-white race/ethnicity, those with diabetes and those with EGFR <30 or 30-59 mL/min/1.73 m(2) had significantly increased odds of anemia. In addition, a significant sex-diabetes interaction was identified; odds of anemia were 4-fold greater in men than women with diabetes relative to sex-matched participants without diabetes.
CONCLUSION: Diabetes was independently correlated with anemia, more so in men than women, and may be linked to premature expression of anemia in persons with moderate reductions in kidney function.

Entities:  

Mesh:

Year:  2005        PMID: 15780101     DOI: 10.1111/j.1523-1755.2005.00226.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  45 in total

1.  Timing of onset of CKD-related metabolic complications.

Authors:  Olivier Moranne; Marc Froissart; Jerome Rossert; Cedric Gauci; Jean-Jacques Boffa; Jean Philippe Haymann; Mona Ben M'rad; Christian Jacquot; Pascal Houillier; Benedicte Stengel; Bruno Fouqueray
Journal:  J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 10.121

2.  Prevalence of anaemia in patients with diabetes mellitus.

Authors:  T J Cawood; U Buckley; A Murray; M Corbett; D Dillon; B Goodwin; S Sreenan
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

3.  Effects of Molidustat in the Treatment of Anemia in CKD.

Authors:  Iain C Macdougall; Tadao Akizawa; Jeffrey S Berns; Thomas Bernhardt; Thilo Krueger
Journal:  Clin J Am Soc Nephrol       Date:  2018-12-17       Impact factor: 8.237

4.  Anaemia in diabetic patients with chronic kidney disease--prevalence and predictors.

Authors:  S Al-Khoury; B Afzali; N Shah; A Covic; S Thomas; D J Goldsmith
Journal:  Diabetologia       Date:  2006-04-12       Impact factor: 10.122

5.  Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study.

Authors:  Charalampos Loutradis; Alexandra Skodra; Panagiotis Georgianos; Panagiota Tolika; Dimitris Alexandrou; Afroditi Avdelidou; Pantelis A Sarafidis
Journal:  World J Nephrol       Date:  2016-07-06

6.  Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Obidiugwu Kenrik Duru; Suying Li; Claudine Jurkovitz; George Bakris; Wendy Brown; Shu-Cheng Chen; Allan Collins; Michael Klag; Peter A McCullough; Janet McGill; Andrew Narva; Pablo Pergola; Ajay Singh; Keith Norris
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

Review 7.  The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.

Authors:  Janice P Lea; Keith Norris; Lawrence Agodoa
Journal:  Am J Nephrol       Date:  2008-04-24       Impact factor: 3.754

8.  Treatment with insulin analogs, especially Glargine and Lispro, associates with better renal function and higher hemoglobin levels in Type 1 diabetic patients with impaired kidney function.

Authors:  Christoph Hasslacher; Felix Kulozik; Justo Lorenzo Bermejo
Journal:  Ther Adv Endocrinol Metab       Date:  2016-05-15       Impact factor: 3.565

9.  The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundation's Kidney Early Evaluation Program.

Authors:  Imran Memon; Keith C Norris; Andrew S Bomback; Carmen Peralta; Suying Li; Shu-Cheng Chen; Peter A McCullough; Adam Whaley-Connell; Claudine Jurkovitz; Manjula Kurella Tamura; Georges Saab
Journal:  Cardiorenal Med       Date:  2013-06-01       Impact factor: 2.041

10.  Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.

Authors:  Finnian R Mc Causland; Brian Claggett; Marc A Pfeffer; Emmanuel A Burdmann; Kai-Uwe Eckardt; Andrew S Levey; John J V McMurray; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert D Toto; Patrick Parfrey
Journal:  Am J Nephrol       Date:  2017-12-14       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.